Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Shonberg

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Chemmedchem|April 27, 2011
Design strategies for bivalent ligands targeting GPCRsJeremy Shonberg, Peter J Scammells, Ben Capuano
Bioorganic & Medicinal Chemistry|February 2, 2015
GPCR crystal structures: Medicinal chemistry in the pocketJeremy Shonberg, Ralf C Kling, Peter Gmeiner, et al.
Journal of Medicinal Chemistry|May 11, 2017
Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for β-Arrestin-Biased D<sub>2</sub>R AgonistsBarbara Männel, Daniela Dengler, Jeremy Shonberg, et al.
Medicinal Research Reviews|May 7, 2014
Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspectiveJeremy Shonberg, Laura Lopez, Peter J Scammells, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2013
Novel adenosine A(2A) receptor ligands: a synthetic, functional and computational investigation of selected literature adenosine A(2A) receptor antagonists for extending into extracellular spaceManuela Jörg, Jeremy Shonberg, Frankie S Mak, et al.
Journal of Medicinal Chemistry|October 22, 2013
A structure-activity analysis of biased agonism at the dopamine D2 receptorJeremy Shonberg, Carmen Klein Herenbrink, Laura López, et al.
Journal of Medicinal Chemistry|June 9, 2015
Structure-activity study of N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a bitopic ligand that acts as a negative allosteric modulator of the dopamine D2 receptorJeremy Shonberg, Christopher Draper-Joyce, Shailesh N Mistry, et al.
Journal of Medicinal Chemistry|August 11, 2015
Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic LigandShailesh N Mistry, Jeremy Shonberg, Christopher J Draper-Joyce, et al.
ACS Chemical Biology|July 25, 2019
Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic AripiprazoleCarmen Klein Herenbrink, Ravi Verma, Herman D Lim, et al.
Nature Communications|April 14, 2023
Constrained catecholamines gain β<sub>2</sub>AR selectivity through allosteric effects on pocket dynamicsXinyu Xu, Jeremy Shonberg, Jonas Kaindl, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Chemmedchem|April 27, 2011
Design strategies for bivalent ligands targeting GPCRsJeremy Shonberg, Peter J Scammells, Ben Capuano
Bioorganic & Medicinal Chemistry|February 2, 2015
GPCR crystal structures: Medicinal chemistry in the pocketJeremy Shonberg, Ralf C Kling, Peter Gmeiner, et al.
Journal of Medicinal Chemistry|May 11, 2017
Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for β-Arrestin-Biased D<sub>2</sub>R AgonistsBarbara Männel, Daniela Dengler, Jeremy Shonberg, et al.
Medicinal Research Reviews|May 7, 2014
Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspectiveJeremy Shonberg, Laura Lopez, Peter J Scammells, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2013
Novel adenosine A(2A) receptor ligands: a synthetic, functional and computational investigation of selected literature adenosine A(2A) receptor antagonists for extending into extracellular spaceManuela Jörg, Jeremy Shonberg, Frankie S Mak, et al.
Journal of Medicinal Chemistry|October 22, 2013
A structure-activity analysis of biased agonism at the dopamine D2 receptorJeremy Shonberg, Carmen Klein Herenbrink, Laura López, et al.
Journal of Medicinal Chemistry|June 9, 2015
Structure-activity study of N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a bitopic ligand that acts as a negative allosteric modulator of the dopamine D2 receptorJeremy Shonberg, Christopher Draper-Joyce, Shailesh N Mistry, et al.
Journal of Medicinal Chemistry|August 11, 2015
Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic LigandShailesh N Mistry, Jeremy Shonberg, Christopher J Draper-Joyce, et al.
ACS Chemical Biology|July 25, 2019
Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic AripiprazoleCarmen Klein Herenbrink, Ravi Verma, Herman D Lim, et al.
Nature Communications|April 14, 2023
Constrained catecholamines gain β<sub>2</sub>AR selectivity through allosteric effects on pocket dynamicsXinyu Xu, Jeremy Shonberg, Jonas Kaindl, et al.
Pageof 2